By Bowling Green Today |
May 17, 2024
On Wednesday, U.S. Senator Rand Paul (R-KY) introduced a resolution under the Congressional Review Act (CRA) to repeal "Medical Devices: Laboratory Developed Tests" (LDTs), a rule recently finalized by the Food and Drug Administration (FDA). The final rule, published on May 6th, seeks to impose regulations on the creation and implementation of laboratory-developed tests, potentially limiting patients' access to critical diagnostic testing. Additionally, these tests are already regulated by the Centers for Medicare & Medicaid Services, and Congress has never given the FDA...